bioRxiv Science⌕ Search
Home/Archive/bioRxiv

bioRxiv · 10.1101/2023.06.12.544556

The oxygen-induced thiosulfate production during Sulfate reduction, Autotrophic denitrification, Nitrification and Anammox (SANIA) integrated process towards next-generation mainstream wastewater treatment

Jiang, C.-k.·Deng, Y.-F.·Chen, G.-H.·Wu, D.
View original source ↗Export metadata ↓

Abstract

This study proposes a novel integrated process: the oxygen-induced thiosulfate production during Sulfate reduction, Autotrophic denitrification, NItrification and Anammox (SANIA) integrated process, targeting to treat mainstream wastewater after organics capture. Three moving-bed biofilm reactors (MBBRs) were applied for oxygen-induced thiosulfate production during sulfate reduction, mixed sulfide- and thiosulfate-driven partial denitrification and anammox (MSPDA), and nitrification (N), respectively. This study firstly established SANIA with supply of mimic nitrifying effluent to investigated the development of MSPDA (Period I) and subsequently verified SANIA in mainstream condition with implementation of nitrification (Period II). In Period I, the MSPDA-MBBR fed with ERATO-MBBR and mimic nitrifying effluent, was operated for over 300 days. Without inoculation of anammox biomass, the high rates of denitratation and anammox being 2.7 gN/(m2{middle dot}d) and 2.8 gN/(m2{middle dot}d), respectively were developed in the bioreactor with the enrichment of anammox bacteria and the coexistence of sulfur-oxidizing bacteria. Batch tests were performed to explore the bioconversion of sulfur and nitrogen compounds in MSPDA with main findings as following: 1) kinetics and pathways of sulfide (S2- S0 SO42-) and thiosulfate (S2 O32- SO42-) oxidation were revealed; 2) fast denitrification was achieved during oxidation of sulfide and thiosulfate to S0 and sulfate, respectively with sufficient nitrite accumulation, supporting the high activity of anammox; 3) nitrite utilization rate of anammox (50.8 mgN/(m2{middle dot}h)) is higher than sulfur-driven denitritation (12.9-42.6 mgN/(m2{middle dot}h)), demonstrating the dominance of anammox in nitrogen removal. In Period II, the N-MBBR was set behind MSPDA-MBBR to supply nitrate by recirculation, thus the SANIA system was developed. Afterwards the integrated SANIA system with a short HRT of 4.7 h was continuously operated for over 130 days. Results demonstrated that 90% of COD, 93% of ammonium and 61% of TIN were removed with concentration of COD, ammonium, and TIN below 10 mg/L, 3 mgN/L and 13 mgN/L, respectively in effluent. Combining with organic capture and SANIA for sewage treatment, the energy-neutral and space-efficient treatment of mainstream wastewater is promising. HighlightsO_LIA new sulfur-cycle process (SANIA) was developed for sewage treatment. C_LIO_LIHigh rates of both denitratation and anammox were developed in MSPDA. C_LIO_LIOxidation of TdS (to S0) and S2O32- (to SO42-) in MSPDA boosts nitrite buildup. C_LIO_LI74-81% of the removed TIN was via anammox in SANIA process. C_LIO_LISANIA with a short HRT of 4.7h achieved good effluent qualities for sewage treatment. C_LI

Explore related subjects

microbiologyPreprint

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Jiang, C.-k., Deng, Y.-F., Chen, G.-H., Wu, D.. 2023-06-12. The oxygen-induced thiosulfate production during Sulfate reduction, Autotrophic denitrification, Nitrification and Anammox (SANIA) integrated process towards next-generation mainstream wastewater treatment. https://doi.org/10.1101/2023.06.12.544556

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

pTRIP, a novel integration plasmid for Listeria monocytogenes

In the past decades, several tools to genetically modify the human pathogen Listeria monocytogenes were developed. Here, we constructed a new integrative plasmid system for L. monocytogenes named pTRIP, for treB insertion plasmid. pTRIP is a vector which stably integrates into the treB locus of the wild type EGD-e. This locus encodes the sole trehalose-specific EIIB and EIIC component of a phosphotransferase system. Successful integration leads to the disruption of treB and thus, to an inability of the resulting L. monocytogenes strains to grow on trehalose as sole carbon source. Due to integration through double homologous recombination, it is the first integrative system which does not require antibiotic selection pressure. To assess functionality of the pTRIP system, prfA and its native promoter region were integrated into the treB locus of a {Delta}prfA strain. Complementation was confirmed in 78% of the isolated clones, indicating successful integration of prfA into the treB locus. We further constructed derivatives of pTRIP harboring the constitutive Pp60 (pTRIP1) and the inducible Prha (pTRIP2) promoter to further expand application possibilities. Microscopic analyses confirmed the functionality of both promoter constructs and showed dose-dependent induction for Prha. pTRIP is an efficient tool for stable gene expression as well as functional studies and expands genetic modification possibilities for L. monocytogenes.

microbiology↗
bioRxiv2026

A rational design strategy and validation for protease-resistant fusion-inhibitor antiviral peptides

Peptide-based fusion inhibitors are promising pharmaceuticals in the fight against enveloped viruses relying on membrane fusion for host infection. However, peptide therapeutic applications have long been hindered by their poor stability in vivo. Here, we discovered that peptide inhibitors with the wildtype sequence of the heptad repeat 2 (HR2) domain of the SARS-CoV-2 spike protein are efficiently cleaved by Transmembrane Protease, Serine 2 (TMPRSS2), a key protease involved in the SARS-CoV-2 virus-cell fusion pathway. We then identified the corresponding cleavage sites and designed three protease-resistant peptides using ranking based on deep mutational scanning and natural occurrence. The three candidates all exhibit inhibitory activity in a cell-cell fusion assay. A high-resolution cryo-EM structure of the top candidate, HR2-NHN, bound to its HR1 target reveals the molecular basis for its potent activity. The top candidate of the cell-based screening assay significantly improved efficacy relative to the wildtype peptide when administered 12 h before infection in both an authentic virus-cell infection assay and a mouse assay. More broadly, our results suggest that the design strategies for protease-resistant peptides could be applied to a broad spectrum of other enveloped viruses and pave the way for the development of safe, prophylactic antivirals that can be administered before exposure.

microbiology↗
bioRxiv2026

Host soluble inositol phosphate signaling promotes coronavirus replication

Coronaviruses rely extensively on host pathways for replication, making host-directed therapies an attractive strategy for broad-spectrum antivirals with reduced risk of viral resistance. Here we identify the host soluble inositol phosphate pathway as a previously unrecognized dependency for coronavirus infection. Genetic or pharmacologic inhibition of several kinases in this pathway markedly suppresses replication of both alpha- and betacoronaviruses, while increasing pathway activity promotes viral replication. We developed UNC7844, a potent multi-target inhibitor of these kinases, which reduces coronavirus replication by more than four orders of magnitude in cultured cells and suppresses coronavirus infection in mice. Mechanistically, UNC7844 suppresses inositol (pyro)phosphates production, disrupts phosphoinositide homeostasis, and impairs late endosomal dynamics, blocking early post-entry steps required for viral genome release and replication. Together, our findings establish the soluble inositol (pyro)phosphate pathway as an important regulator of coronavirus infection and highlight its inhibition as a promising host-directed antiviral strategy.

microbiology↗